LenioBio
ApprovedDiscover LenioBio's innovative protein expression technology, ALiCE®, for rapid and scalable protein production. Ideal for research, drug development, and industrial applications.
Founded
2017
Focus
BiologicsProteomicsAntibodies
About
Discover LenioBio's innovative protein expression technology, ALiCE®, for rapid and scalable protein production. Ideal for research, drug development, and industrial applications.
Funding History
2Total raised: $24.3M
Series A$20MBoehringer Ingelheim Venture FundJun 15, 2022
Seed$4.3MHigh-Tech GründerfondsSep 15, 2020
Company Info
TypePrivate
Founded2017
LocationAachen, Germany
StageApproved
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile